Search Results 1971-1980 of 15587 for Orange Peel tea

1. A Study To Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) For Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for 5 years prior to randomization. Cancers with a negligible risk of ...

2. Phase 2 Study Of TAK-341 For Multiple System Atrophy - Mayo Clinic

   ... skin, or body. Ophthalmic abnormalities. The following are considered exclusionary: Ophthalmic abnormalities and conditions that, in the judgment of the ...

3. Sym021 In Combination With Either Sym022 Or Sym023 Or Sym023 And Irinotecan In Patients With Advanced Biliary Tract Carcinomas - Mayo Clinic

   The purpose of this study is to evaluate the preliminary effectiveness of the 3 combinations (Sym021+Sym022 and Sym021+Sym023 and Sym023+Irinotecan) in Biliary ...

4. Cisplatin, Intensity-Modulated Radiation Therapy, And Pembrolizumab In Treating Patients With Stage III-IV Head And Neck Squamous Cell Carcinoma - Mayo Clinic

   Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 1095 days (3 years); noninvasive cancers (for example ...

5. A Study To Evaluate Ribociclib Plus Letrozole To Treat Cancer Of The Ovary, Fallopian Tube Or Peritoneum - Mayo Clinic

   ... skin cancer or curatively resected cervical cancer. Patients with known brain metastases are excluded. Patients with central nervous system (CNS) ...

6. A Phase 2, Multi-center, Open-label Study To Evaluate The Efficacy And Safety Of Luspatercept (ACE-536) In Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia With And Without Red Blood Cell-Transfusion Dependence - Mayo Clinic

   A Phase 2, Multi-center, Open-label Study To Evaluate The Efficacy And Safety Of Luspatercept (ACE-536) In Subjects With Myeloproliferative Neoplasm-Associated ...

7. Study To Evaluate The Safety And Effectiveness Of BMS-986036 In Adults With Nonalcoholic Steatophepatitis (NASH) And Compensated Liver Cirrhosis - Mayo Clinic

   History of cancer within the last 5 years (other than treated and believed to be cured basal or squamous cell carcinoma of the skin or resected carcinoma of the ...

8. Molecularly Targeted Therapy In Treating Patients With BRAF Wild-type Melanoma That Is Metastatic - Mayo Clinic

   ... skin, or an in situ malignancy. Patients with a low grade prostate cancer, not on hormonal therapy, for which the disease is confined to the prostate may be ...

9. Intrathecally Administered Gene Therapy APB-102 In Rapidly Progressive ALS Patients With SOD1 Mutations - Mayo Clinic

   ... skin infection at or near the lumbar puncture site, indications of possible raised intracranial pressure, abnormal spine skeletal issues);; Physically and ...

10. Belantamab, Lenalidomide, And Daratumumab For Newly-diagnosed Multiple Myeloma - Mayo Clinic

    Lenalidomide is an immunomodulatory drug (altering the immune effects on the tumor cell). Daratumumab is a drug that is a monoclonal antibody that is directed ...